Exosomes Diagnostics And Therapeutics Market: Emerging Trends And Market Driver Analysis

Table of Contents

Chapter 1. Market Overview & Competitive Landscape
                    1.1. Global Market Size Estimates & Forecasts (2021 - 2033)
                    1.2. Competitive Landscape Analysis
                        1.2.1. Key Players & Emerging Startups
                        1.2.2. Regional Coverage and Study Assumptions
                            1.2.2.1. North America
                            1.2.2.2. Europe
                            1.2.2.3. Asia Pacific
                            1.2.2.4. Rest of World
Chapter 2. Growth Drivers & Technological Advancements
                    2.1. Key Market Growth Drivers
                        2.1.1. Increasing Adoption of Non-invasive Diagnostic Tools
                        2.1.2. Expanding Role of Precision & Personalized Medicine
                        2.1.3. Advancements in Clinical Research for Exosome-based Therapeutics
                        2.1.4. Growing Biopharma & Government R&D Investments
                    2.2. Technological Innovations
                        2.2.1. Progress in Exosome Isolation, Purification, and Characterization
                        2.2.2. Development of Analytical & High-throughput Platforms
                        2.2.3. Emergence of Exosome-based Drug Delivery Systems
                    2.3. Key Market Challenges
                    2.4. Key Market Opportunities
Chapter 3. Emerging Market Trends
                    3.1. Integration of AI & Machine Learning in Exosome Biomarker Discovery
                    3.2. Expansion of Liquid Biopsy and Multi-omics Integration
                    3.3. Increasing Academic–Industry Collaborations
                    3.4. Commercialization of Exosome-based Diagnostic Kits & Therapeutics
                    3.5. Evolving Regulatory Frameworks & Clinical Translation Pathways
Chapter 4. Competitive Landscape
                    4.1. Market Structure & Competitive Positioning
                    4.2. Key Market Players
                        4.2.1. Thermo Fisher Scientific, Inc.
                            4.2.1.1. Company Overview
                            4.2.1.2. Product Portfolio
                            4.2.1.3. Financial Statements
                            4.2.1.4. Strategic Initiatives
                        4.2.2. Bio-Techne Corporation
                        4.2.3. Qiagen N.V.
                        4.2.4. Lonza Group AG
                        4.2.5. Exosome Diagnostics, Inc.
                        4.2.6. NanoSomix, Inc.
                        4.2.7. Danaher Corporation
                        4.2.8. System Biosciences, LLC
                        4.2.9. Miltenyi Biotec
                        4.2.10. Aethlon Medical, Inc.
                        4.2.11. Norgen Biotek Corp.
                        4.2.12. Creative Biolabs, Inc.
                        4.2.13. Evox Therapeutics Ltd.
                        4.2.14. Codiak BioSciences, Inc.
                        4.2.15. Capricor Therapeutics, Inc.